Showing 1 - 20 results of 24 for search '"glaucoma"', query time: 0.09s Refine Results
  1. 1
  2. 2

    Efficacy and safety of selective laser trabeculoplasty for uveitic glaucoma by Minako Suzuki, Masaki Takeuchi, Akira Meguro, Jutaro Nakamura, Mamoru Tateishi, Miki Fukuda, Akihiro Kamata, Yuki Mizuki, Kayoko Yamada, Etsuko Shibuya, Norihiro Yamada, Mami Ishihara, Nobuhisa Mizuki

    Published 2025-02-01
    “…Abstract To determine the efficacy and safety of selective laser trabeculoplasty (SLT) in patients with uveitic glaucoma, we retrospectively evaluated 17 eyes from 13 consecutive uveitic glaucoma cases who were treated with SLT due to inadequate interocular pressure (IOP) control despite glaucoma medical therapy. …”
    Get full text
    Article
  3. 3
  4. 4
  5. 5

    Improving compliance and evaluating physician–patient concerns in glaucoma: a pilot study by Mohannad Albdour, Aaron Shi, Chuhan Wang, Ibrahim Saleh, Karanjit S Kooner

    Published 2023-10-01
    “… Purpose: To improve glaucoma treatment compliance via education, medication reminders, and understanding of patient and physician concerns. …”
    Get full text
    Article
  6. 6

    Comparison of handheld rebound tonometry with Goldmann applanation tonometry in children with glaucoma: a cohort study by Catey Bunce, Peng Tee Khaw, John Brookes, Maria Papadopoulos, Amanda Lewis, Poornima Rai, Renata Puertas, Annegret Hella Dahlmann-Noor, Shenille Tabasa-Lim, Ahmed El-Karmouty, Mustafa Kadhim, Nicholas Kloster Wride, Dawn Grosvenor

    Published 2013-04-01
    “…Objective To test agreement of two methods to measure intraocular pressure (IOP): rebound tonometry (RBT) and gold standard Goldmann applanation tonometry (GAT) in children with glaucoma.Design Observational prospective cohort study.Setting Tertiary paediatric glaucoma clinic at a single centre.Participants 102 individuals attending a paediatric glaucoma clinic, mean (SD) age 11.85 (3.17), of whom 53 were male.Primary and secondary outcome measures Intraocular pressure, central corneal thickness, child preference for measurement method.Results Limits of agreement for intraobserver and interobserver were, respectively, (−2.71, 2.98) mm Hg and (−5.75, 5.97) mm Hg. …”
    Get full text
    Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Association of arterial stiffness and eye disease: a systematic review and meta-analysis by Robert Scragg, Angela L Beros, John D Sluyter

    Published 2025-01-01
    “…The 19 cohort studies identified (five for AMD, three for glaucoma, one for RVO and 10 for retinopathy) indicated overall that increased arterial stiffness was associated with the future development of eye disease.Conclusions Higher arterial stiffness is associated with AMD, glaucoma, RVO and retinopathyPROSPERO registration number CRD42019129563.…”
    Get full text
    Article
  15. 15

    Anti-vascular Endothelial Growth Factor Outpatient Treatment Patterns in Patients with Exudative Age-related Macular Degeneration from a Japanese Hospital Claims Database by Tomohiro Iida, Aya Narimatsu, Kenji Adachi, Edward CY Wang

    Published 2014-07-01
    “…Of these, 68 patients were treated for at least 12 months (all with ranibizumab PRN), and 29 had neither cataracts nor glaucoma and were included in the treatment pattern analysis. …”
    Get full text
    Article
  16. 16

    Attendance of Patients with ophthalmological problems about Eye Protection from UV/blue Light Radiation from Sun light and Electronic Devices in Sulaimani City by Salah Qadir Mahmood, Muhammad Babakir-Mina, Salar Ibrahim Ali, Abdulrahman M. Ibrahem, Bakhtyar Kamal Talabany

    Published 2018-07-01
    “…Most of participants had knowledge about the effects of UV/blue light on eye diseases by (52%), cataract (57.8%), glaucoma and red eye with percentage of (45.8%) and (43.4%) respectively. …”
    Get full text
    Article
  17. 17

    From bench to bedside: Developing CRISPR/Cas-based therapy for ocular diseases by Qing Zhao, Linxin Wei, Youxin Chen

    Published 2025-03-01
    “…To date, active trials include treatments for primary open angle glaucoma with MYOC mutations, refractory herpetic viral keratitis, CEP290-associated inherited retinal degenerations, neovascular age-related macular degeneration, and retinitis pigmentosa with RHO mutations. …”
    Get full text
    Article
  18. 18

    Open challenges for the automatic synthesis of clinical trials by Olivia Sanchez-Graillet, David M. Schmidt, Christian Kullik, Philipp Cimiano

    Published 2025-02-01
    “…To address this challenge, we utilized our annotated dataset, which includes 211 abstracts of clinical trials related to glaucoma and type 2 diabetes mellitus. We then developed a tool that provides an overview of the annotated clinical trial information and enables users to group them by outcomes. …”
    Get full text
    Article
  19. 19

    A combination of topical and systemic administration of brimonidine is neuroprotective in the murine optic nerve crush model. by Ruta Maciulaitiene, Giedrius Kalesnykas, Dainius Haroldas Pauza, Ingrida Januleviciene

    Published 2024-01-01
    “…Glaucoma is a multifactorial optic neuropathy that primarily affecting retinal ganglion cells (RGC). …”
    Get full text
    Article
  20. 20

    A multidimensional study for design of phytochemical profiling, antioxidant potential, and enzyme inhibition effects of ışgın (Rheum telianum) as an edible plant by Ahmet Zafer Tel, Kubra Aslan, Mustafa Abdullah Yılmaz, İlhami Gulcin

    Published 2025-01-01
    “…The inhibition effects of both leaves and the seeds of the R. telianum extracts on acetylcholinesterase and butyrylcholinesterase, α-glycosidase and human carbonic anhydrases II isoenzyme enzymes, which associated with some global diseases including Alzheimer's disease, type-2 diabetes mellitus and glaucoma were determined. In conclusion, the extracts' contents and functional relationship and the plants' possible usage in the food, medicine, and cosmetic industries was revealed.…”
    Get full text
    Article